|
SLC35B3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.35469999451976E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62953999999216E-05 |
| Normal-vs-Stage2 |
2.602400E-02 |
| Normal-vs-Stage3 |
3.87279999958245E-07 |
| Normal-vs-Stage4 |
1.952450E-04 |
| Stage1-vs-Stage2 |
5.202600E-01 |
| Stage1-vs-Stage3 |
1.596830E-01 |
| Stage1-vs-Stage4 |
9.443200E-01 |
| Stage2-vs-Stage3 |
1.985020E-01 |
| Stage2-vs-Stage4 |
5.871600E-01 |
| Stage3-vs-Stage4 |
2.746600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.86970000487707E-08 |
| Normal-vs-AfricanAmerican |
1.817880E-04 |
| Normal-vs-Asian |
5.420800E-01 |
| Caucasian-vs-AfricanAmerican |
8.235000E-01 |
| Caucasian-vs-Asian |
2.211400E-01 |
| AfricanAmerican-vs-Asian |
2.290600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.29679999999666E-06 |
| Normal-vs-Female |
8.99070000004443E-07 |
| Male-vs-Female |
2.860600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.921300E-03 |
| Normal-vs-Age(41-60Yrs) |
7.98680000000385E-05 |
| Normal-vs-Age(61-80Yrs) |
8.58599999986609E-07 |
| Normal-vs-Age(81-100Yrs) |
2.794300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.974200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.421400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.371600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.158560E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.239000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.492400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.236100E-04 |
| Normal-vs-Grade 2 |
1.221470E-04 |
| Normal-vs-Grade 3 |
2.67959999999956E-06 |
| Normal-vs-Grade 4 |
9.13439999972177E-07 |
| Grade 1-vs-Grade 2 |
4.410000E-01 |
| Grade 1-vs-Grade 3 |
9.752800E-01 |
| Grade 1-vs-Grade 4 |
2.995800E-01 |
| Grade 2-vs-Grade 3 |
1.916990E-01 |
| Grade 2-vs-Grade 4 |
3.440500E-02 |
| Grade 3-vs-Grade 4 |
1.732360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.978700E-04 |
| Normal-vs-ccB subtype |
1.90150999999084E-05 |
| ccA subtype-vs-ccB subtype |
1.812590E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.70650000000028E-05 |
| Normal-vs-N1 |
1.735590E-01 |
| N0-vs-N1 |
5.140000E-01 |
|
|
